2016 (# Publications - 5)
Radhakrishnan, A., Nanjappa, V., Raja, R., Sathe, G., Puttamallesh, V. N., Jain, A. P., Pinto, S. M., Balaji, S. A., Chavan, S., Sahasrabuddhe, N. A., Mathur, P. P., Kumar, M. M., Prasad, T. S. K., Santosh, V., Sukumar, G., Califano, J. A., Rangarajan, A., Sidransky, D., Pandey, A., Gowda, H. and Chatterjee, A. (2016). A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma. Scientific Reports. [PubMed]
Rajagopalan, P., Nanjappa, V., Raja, R. , Jain, A. P., Mangalparthi, K. K., Sathe, G. J., Babu, N., Patel, K., Cavusoglu, N., Soeur, J., Pandey, A., Roy, N., Breton, L., Chatterjee, A., Misra, N. and Gowda, H. (2016). How does chronic cigarette smoke exposure affect human skin? A global proteomics study in primary human keratinocytes. OMICS: A Journal of Integrative Biology. 20, 615-626. [PubMed]
Raja, R., Sahasrabuddhe, N. A., Radhakrishnan, A., Syed, N., Solanki, H. S., Puttamallesh V. N., Balaji S. A., Nanjappa V., Datta, K. K., Babu, N., Renuse, S., Patil, A. H., Izumchenko, E., Prasad, T. S., Chang X., Rangarajan A., Sidransky, D., Pandey, A., Gowda, H., Chatterjee, A. (2016). Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells. Oncotarget. [PubMed]
Yelamanchi, S. D., Solanki, H. S., Radhakrishnan, A., Balakrishnan, L., Advani, J., Raja, R. , Sahasrabuddhe, N. A., Mathur, P. P., Dutta, P., Prasad, T. S. K., Korbonits, M., Chatterjee, A., Gowda, H., Mukherjee, K. K. (2016). Signaling network map of aryl hydrocarbon receptor. Journal of Cell Communication and Signaling. [PubMed]
Radhakrishnan, A., Nanjappa, V., Raja, R., Sathe, G. J., Chavan, S., Nirujogi, R. S., Patil, A., Solanki, H., Renuse, S., Sahasrabuddhe, N. A., Mathur, P. P., Prasad, T. S. K., Kumar, P., Califano, J. A., Sidransky, D., Pandey, A., Gowda, H. and Chatterjee, A. (2016). Dysregulation of splicing proteins in head and neck squamous cell carcinoma. Cancer Biology and Therapy. 17, 219-248. [PubMed]
2015 (# Publications - 4)
Nanjappa, V., Renuse, S., Raja, R., Syed, N., Sathe, G., Radhakrishnan, A., Subbannayya, Y., Sahasrabuddhe, N. A., Patil, A., Marimuthu, A., Guerrero-Preston, R., Somani, B. L., Nair, B., Prasad, T. S. K., Gowda, H., Califano, J. A., Sidransky, D., Pandey, A. and Chatterjee, A. (2015). Chronic exposure to chewing tobacco induces growth in normal oral cells via overexpression of Stearoyl-CoA desaturase. Cancer Biology and Therapy. 16, 1593-603. [PubMed]
Subbannayya, T., Rojas, P. L., Barbhuiya, M. A., Raja, R., Renuse, S., Sathe, G., Pinto, S. M., Syed, N., Nanjappa, V., Patil, A. H., Garcia, P., Nair, B., Guerrero-Preston, R., Navani, S., Sahasrabuddhe, N. A., Santosh, V., Tiwari, P. K., Prasad, T. S. K., Gowda, H., Sidransky, D., Pandey, A., Roa, J. C. and Chatterjee A. (2015). Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. BMC Cancer. 15, 843 [PubMed]
Subbannayya, Y., Syed, N., Barbhuiya, M. A., Raja, R., Marimuthu, A., Sahasrabuddhe, N.,Pinto, S. M., Srikanth, S. M., Renuse, S., Manju, H. C., Zameer. M. A. L., Sharma, J., Kotteazeth, Srikumar., Rajagopalan, S., Waddell, K., Roa, J. C., Kumar, V., Kumar, K.V.V., Prasad, T. S. K., Ramaswamy, G., Kumar, R. V., Pandey, A., Gowda, H. and Chatterjee, A. (2015). Calcium calmodulin dependent kinase kinase 2 - a potential therapeutic target for
gastric adenocarcinoma. Cancer Biology and Therapy. 16, 336-45 [PubMed]
Syed, N., Chavan, S., Sahasrabuddhe, N., Renuse, S., Sathe, G., Nanjappa, V.,Radhakrishnan, A., Raja, R., Srinivasan, A., Prasad, T.S.K., Srikumar, K., Gowda H., Santosh, V., Sidransky, D., Califano, J. A., Pandey, A. and Chatterjee, A. (2015). Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma. Proteomics. 15, 383-93. [PubMed]
2014 (# Publications - 5)
Taware, R., Abnave, P., Patil, D., Rajamohanan, P. R., Raja, R., Soundararajan, G., Kundu ,G.C., Kharat, M. K. D., Pai, K. and Ahmed, A. (2014). Trichothecin from endophytic fungus Trichothecium sp. and its anticancer effect on murine melanoma and breast cancer cell lines. Current Biochemical Engineering. 2, 73-80. [PubMed]
Raja, R., Kale, S., Thorat, D., Soundararajan, G., Lohite, K., Mane, A., Karnik, S. and Kundu, G.C. (2014). Hypoxia driven osteopontin contributes to breast tumor progression through modulation of HIF1α mediated VEGF dependent angiogenesis. Oncogene. 33, 2053-2064. [PubMed]
Kale, S., Raja, R., Thorat, D., Soundararajan, G., Patil, T. and Kundu, G.C. (2014). Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Oncogene. 33, 2295-2306. [PubMed]
Taware, R. V., Abnave, P. B., Patil, D., Rajamohanan, P. R., Raja, R., Soundararajan, G., Kundu, G. C. and Ahmad, A. (2014). Isolation, purification and characterization of Trichothecinol-A produced by endophytic fungus Trichothecium sp. and its antifungal, anticancer and antimetastatic activities. Sustainable Chemical Processes. 2; 8.
Bandopadhyay, M., Bulbule, A., Butti, R., Chakraborty, G., Ghorpade, P., Ghosh, P., Gorain, M., Kale,S., Kumar, D., Kumar, S., Roy, G., Sharma, P., Shetti, D., Soundararajan, G., Thorat, D., Tomar, D., Nalukurthi, R., Raja, R., Mishra, R., Totakura, S., Yadav, A. and Kundu, G.C. (2014). Osteopontin as a therapeutic target for cancer. Expert Opinion on Therapeutic Targets. 18: 883-895. [PubMed]
2013 (# Publications - 1)
Syed A, Raja R., Kundu G. C., Gambhir S. and Ahmad A. (2013). Extracellular Biosynthesisof Monodispersed Gold Nanoparticles, Their Characterization, Cytotoxicity Assay, Biodistribution and Conjugation with Doxorubicin. Journal of Nanomedicine and Nanotechnology. 4: 156. [PubMed]
2011 (# Publications - 1)
Ahmed, M., Behera, R., Chakraborty, G., Jain, S., Kumar, V., Sharma, P., Bulbule, A., Kale, S., Kumar, S., Mishra, R., Raja, R., Saraswati, S., Kaur, R., Soundararajan, G., Kumar, D., Sanyal, M., Ramdasi, A., Ghosh, P. and Kundu, G. C. (2011). Osteopontin: a potentially important therapeutic target in cancer. Expert Opinion on Therapeutic Targets. 15, 1113-1126. [PubMed]
2008 (# Publications - 2)
Jain, S., Chakraborty, G., Raja, R., Kale, S. and Kundu, G. C. (2008). Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Research. 68, 7750-7759. [PubMed]
Chakraborty G., Jain, S., Kale, S., Raja, R., Kumar, S., Mishra, R. and Kundu, G. C. (2008). Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. Molecular Medicine Reports. 1, 641-646. [PubMed]
|